Lv0
0 积分 2023-12-21 加入
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
1小时前
待确认
Single Chelator–Minibody Theranostic Agents for89Zr PET Imaging and177Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
3个月前
已关闭
Development of a [89Zr]Zr-labeled human antibody using a novel phage-displayed human scFv library
8个月前
已完结
Homodimeric peptide radiotracer [68Ga]Ga-NOTA-(TMVP1)2 for VEGFR-3 imaging of cervical cancer patients
9个月前
已完结
Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent
9个月前
已完结
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody
10个月前
已完结
First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
10个月前
已完结
Microarray-Based CD38 Peptide Probe Screening for Multiple Myeloma Imaging
10个月前
已完结
Antibody–drug conjugates come of age in oncology
10个月前
已完结
Radioimmunotherapy of human tumours
10个月前
已完结
皖公网安备34019202002308
